Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Heart Failure Patients Undergoing Hip Fracture Surgery
NCT01022983Phase 4Withdrawn
- Sponsor
- Sykehuset i Vestfold
- Start
- Apr 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in heart failure (HF) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Highest NT-proBNP-value at 7 days. Planned start Apr 2011; status: withdrawn.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01022983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01022983.